Personalized Versus Precision Nanomedicine for Treatment of Ovarian Cancer.
Saved in:
| Title: | Personalized Versus Precision Nanomedicine for Treatment of Ovarian Cancer. |
|---|---|
| Authors: | Garbuzenko OB; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers the State University of New Jersey, Piscataway, NJ, 08854, USA., Sapiezynski J; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers the State University of New Jersey, Piscataway, NJ, 08854, USA., Girda E; Department of Gynecology Oncology, Robert Wood Johnson School of Medicine, Rutgers the State University of New Jersey, New Brunswick, NJ, 08901, USA.; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, 08901, USA., Rodriguez-Rodriguez L; Department of Surgery, Division of Gynecologic Oncology, City of Hope National Medical Center, Duarte, CA, 91010, USA., Minko T; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers the State University of New Jersey, Piscataway, NJ, 08854, USA.; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, 08901, USA. |
| Source: | Small (Weinheim an der Bergstrasse, Germany) [Small] 2024 Oct; Vol. 20 (41), pp. e2307462. Date of Electronic Publication: 2024 Feb 11. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101235338 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1613-6829 (Electronic) Linking ISSN: 16136810 NLM ISO Abbreviation: Small Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
